Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alona Zer

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Journal of Global Oncology|May 9, 2019
Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better SurvivalAnna May Suidan, Laila Roisman, Anna Belilovski Rozenblum, et al.
Radiology and Oncology|April 21, 2020
Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplantAssaf Moore, Mordechai R Kramer, Dror Rosengarten, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastasesElizabeth Dudnik, Shlomit Yust-Katz, Hovav Nechushtan, et al.
Tumori|February 17, 2021
Association between multitarget tyrosine kinase inhibitors and changes in CT appearance of submucosal fat in the gastrointestinal tractShlomit Tamir, Shlomo Gavrielli, Chen Abitbol, et al.
Journal of the National Cancer Institute|October 24, 2017
A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung CancerDaniel A Goldstein, Noa Gordon, Michal Davidescu, et al.
Oncoimmunology|August 19, 2021
Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancerYosef Landman, Oded Jacobi, Noga Kurman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Cardiac mass in a rapidly deteriorating patientAlona Zer, Pnina Green, Osnat Moreh-Rahav, et al.
Thoracic Cancer|June 18, 2020
Can Ipilimumab restore immune response in advanced NSCLC after progression on anti-PD-1/PD-L1 agents?Michal Sternschuss, Nir Peled, Aaron M Allen, et al.
Chemotherapy|March 2, 2012
Tailoring neoadjuvant chemotherapy for locally advanced breast cancer: a historical prospective studyAlona Zer, Shulamit Rizel, Rony Braunstein, et al.
Oncology|April 23, 2018
High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung CancerAaron M Allen, Tzippy Shochat, Dov Flex, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Journal of Global Oncology|May 9, 2019
Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better SurvivalAnna May Suidan, Laila Roisman, Anna Belilovski Rozenblum, et al.
Radiology and Oncology|April 21, 2020
Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplantAssaf Moore, Mordechai R Kramer, Dror Rosengarten, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastasesElizabeth Dudnik, Shlomit Yust-Katz, Hovav Nechushtan, et al.
Tumori|February 17, 2021
Association between multitarget tyrosine kinase inhibitors and changes in CT appearance of submucosal fat in the gastrointestinal tractShlomit Tamir, Shlomo Gavrielli, Chen Abitbol, et al.
Journal of the National Cancer Institute|October 24, 2017
A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung CancerDaniel A Goldstein, Noa Gordon, Michal Davidescu, et al.
Oncoimmunology|August 19, 2021
Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancerYosef Landman, Oded Jacobi, Noga Kurman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Cardiac mass in a rapidly deteriorating patientAlona Zer, Pnina Green, Osnat Moreh-Rahav, et al.
Thoracic Cancer|June 18, 2020
Can Ipilimumab restore immune response in advanced NSCLC after progression on anti-PD-1/PD-L1 agents?Michal Sternschuss, Nir Peled, Aaron M Allen, et al.
Chemotherapy|March 2, 2012
Tailoring neoadjuvant chemotherapy for locally advanced breast cancer: a historical prospective studyAlona Zer, Shulamit Rizel, Rony Braunstein, et al.
Oncology|April 23, 2018
High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung CancerAaron M Allen, Tzippy Shochat, Dov Flex, et al.
Pageof 10